Viage Therapeutics
PrivateLast Round
Seed
Jan 6, 2022
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Viage Therapeutics is a biotechnology company that develops drugs to treat psychiatric and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Viage Therapeutics Comparables
Compare Viage Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stellate Therapeutics Inc. | 84% | |
| Axial Therapeutics | 77% | |
| Holobiome | 73% | |
Viage Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 6, 2022 |
Viage Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Remiges Ventures | Seed |
| ANRI株式会社 | Seed |
| Miyako Capital | Seed |
| Kyoto University Innovation Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 117% MoM.
- Jun 21, 2026
Monthly visitors increased 200% MoM, reaching 608.
Viage Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Viage Therapeutics's valuation, stock price, and market status.